Skip to content

Comparative study on the curative effect of axillary approach endoscopic thyroidectomy and open surgery

Comparative study on the curative effect of axillary approach endoscopic thyroidectomy and open surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049474
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

Case series:No

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 75 years; 2. Preoperative pathological biopsy showed unilateral glandular papillary carcinoma with diameter <=2cm without extracapsular involvement, no distant metastasis, no lymph node metastasis or limited to level VI lymph nodes; no hoarseness before surgery; 3. Normal thyroid function, no cognitive impairment, no language communication impairment; 4. Patients and their families agreed to participate in this study and signed the informed consent form for surgery.

Exclusion criteria

Exclusion criteria: 1. Preoperative imaging showed that the tumor location was close to the tracheoesophageal groove; 2. Preoperative vocal cord movement limitation; history of neck surgery or neck radiotherapy; 3. Local infection, inflammation or burn, etc.; abnormal coagulation function; 4. Patients with severe liver and kidney insufficiency and systemic infectious diseases; 5. Patients who have undergone any anti-tumor therapy before surgery.

Design outcomes

Primary

MeasureTime frame
Surgical efficacy;

Countries

China

Contacts

Public ContactMiao Beiping

Shenzhen Second People's Hospital

miaobeiping@163.com+86 13923765937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026